Report No. 1: Follow-up on the Use of Convupidiol® in Patients with Refractory (Drug-Resistant) Epilepsy
01/05/2023
Marketing Authorization Holder (MAH): Alef Medical Argentina S.A.
Pharmacovigilance Team / IPRAT S.A.
Date: April 1, 2022
Back